The effect of early trough level of infliximab on subsequent disease course in patients with Crohn disease: A prospective cohort study

Decreased trough level of infliximab (TLI) is associated with diminished efficacy in patients with Crohn disease (CD). We examined whether TLI at 14 weeks subsequent to the start of infliximab (IFX) treatment would impact long-term clinical course. Serum IFX levels and antibodies to IFX (ATI) at 14...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Medicine (Baltimore)
Hlavní autoři: Ishida, Natsuki, Miyazu, Takahiro, Sugiyama, Tomohiro, Tamura, Satoshi, Kagami, Takuma, Tani, Shinya, Yamade, Mihoko, Iwaizumi, Moriya, Hamaya, Yasushi, Osawa, Satoshi, Furuta, Takahisa, Sugimoto, Ken
Médium: Artigo
Jazyk:Inglês
Vydáno: Wolters Kluwer Health 2020
Témata:
4500
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7373619/
https://ncbi.nlm.nih.gov/pubmed/32702894
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000021226
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky